The Future of OEM Blood Analyzers: How AI + Complete Blood Morphology is Reshaping Diagnostics

The global hematology analyzer market is experiencing unprecedented transformation. Valued at $4.33 billion in 2025 and projected to reach $7.28 billion by 2034, this market reflects a fundamental shift in how laboratories approach blood diagnostics. At the heart of this evolution lies a critical convergence: artificial intelligence meets complete blood morphology (CBM), and manufacturers like […]

The Future of OEM Blood Analyzers: How AI + Complete Blood Morphology is Reshaping Diagnostics Read More »